The peptide activates extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation in a dose-dependent manner, leading to nuclear translocation and activation of transcription factors including c-Fos, c-Jun, and early growth response-1 (Egr-1) that drive expression of genes involved in cell growth, migration, and angiogenesis
Side Effects and Tolerability All three products share the gastrointestinal side effect profile associated with GLP-1 receptor agonism: nausea, vomiting, diarrhoea, constipation, and abdominal discomfort are the most commonly reported adverse events, typically emerging during dose escalation and improving over time
I.DudaJ
Any visceral fat reduction benefits specific to the GH pathway would gradually diminish, but overall weight loss from retatrutide would continue
Regulatory peptides involved in the healing of various tissues and gum regeneration, capable of reducing inflammation, are of particular interest